Belisle J T, McNeil M R, Chatterjee D, Inamine J M, Brennan P J
Department of Microbiology, Colorado State University, Fort Collins 80523.
J Biol Chem. 1993 May 15;268(14):10510-6.
Toward studying the genetics, biosynthesis, and roles in the pathogenesis of the dominant surface glycopeptidolipid antigens of Mycobacterium avium, rough colony variants of M. avium serovar 2 were picked, cultured in quantity, and their lipid composition examined. Two of the rough (Rg) variants, Rg-3 and Rg-4, were devoid of glycopeptidolipids or any more elemental structures and thus were similar to those described previously. Two others, Rg-0 and Rg-1, each contained two novel lipopeptides, devoid of any of the carbohydrate substituents that confer serotypic activity on the glycopeptidolipids. The application of gas chromatography, fast atom bombardment-mass spectrometry and 1H NMR to lipopeptide I established the structure C32:2-beta-OH-fatty acyl-D-Phe-D-allo-Thr-D-Ala-L-alaninol. Lipopeptide II represented a minor variation of this structure: C32:1-beta-OH-fatty acyl-D-Phe-D-allo-Thr-D-Ala-L-alaninol. These newly discovered lipopeptides are identical to the fatty acyl-tripeptide-amino alcohol "core" component of the glycopeptidolipids of the M. avium complex, and thus the Rg-0 and Rg-1 variants represent a form of "deep rough" mutation in M. avium. Separately, we report that these rough variants of M. avium differ genetically from the smooth, virulent form by major deletions of portions of the genes responsible for glycopeptidolipid synthesis (Belisle, J. T., Klaczkiewicz, K., Brennan, P. J., Jacobs, W. R., Jr., and Inamine, J. M. (1993) J. Biol. Chem. 268, 10517-10523). The isolation of different sets of spontaneous mutants of M. avium differentially defective in the capacity to synthesize glycopeptidolipids provides the means to explore their biosynthesis and roles in opportunistic pathogenesis.
为了研究鸟分枝杆菌主要表面糖肽脂抗原的遗传学、生物合成及其在发病机制中的作用,挑选了鸟分枝杆菌血清型2的粗糙菌落变体,大量培养并检测其脂质组成。其中两个粗糙(Rg)变体Rg-3和Rg-4不含糖肽脂或任何更基本的结构,因此与先前描述的类似。另外两个变体Rg-0和Rg-1,各自含有两种新型脂肽,缺乏赋予糖肽脂血清型活性的任何碳水化合物取代基。气相色谱、快原子轰击质谱和1H NMR对脂肽I的应用确定了其结构为C32:2-β-OH-脂肪酰基-D-苯丙氨酸-D-别苏氨酸-D-丙氨酸-L-丙氨醇。脂肽II代表该结构的一个微小变体:C32:1-β-OH-脂肪酰基-D-苯丙氨酸-D-别苏氨酸-D-丙氨酸-L-丙氨醇。这些新发现的脂肽与鸟分枝杆菌复合群糖肽脂的脂肪酰基-三肽-氨基醇“核心”成分相同,因此Rg-0和Rg-1变体代表了鸟分枝杆菌中一种“深度粗糙”突变形式。另外,我们报道这些鸟分枝杆菌的粗糙变体在基因上与光滑、有毒力的形式不同,负责糖肽脂合成的部分基因有大量缺失(贝利瑟尔,J.T.,克拉茨基维茨,K.,布伦南,P.J.,雅各布斯,W.R.,Jr.,和稻岭,J.M.(1993年)《生物化学杂志》268,10517 - 10523)。分离出在合成糖肽脂能力上有不同缺陷的不同组鸟分枝杆菌自发突变体,为探索其生物合成及其在机会性发病机制中的作用提供了手段。